Clinical Trial Update: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers [Phase 2]

View source ↗

Summary

Phase II trial of ZIO-101 for advanced blood and bone marrow cancers has completed, sponsored by Alaunos Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• ZIO-101

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Hematologic Neoplasms, Bone Marrow Neoplasms | Phase 2 | Status: COMPLETED